Leviticus Cardio
Wireless Solution for VAD Implants
Company Overview
Snapshot
Founded in February 2008 by Michael Zilbershlag, Yigal Kassif, and Moshe Levy, Leviticus Cardio operated with 1–10 employees. The company raised a total of $5.77 million across 5 funding rounds from 2 investors. In January 2019, Leviticus Cardio and Jarvik Heart were awarded an R&D grant from the BIRD Foundation.
Business overview
Leviticus Cardio developed a wireless system designed to provide day-to-day power for implanted ventricular assist devices (VADs), aiming to eliminate complications associated with drive lines. The company's core technology, Coplanar Energy Transfer (CET), is compatible with existing commercial VADs. This system utilizes an implanted receiver coil and an external chest-worn transmitter coil to inductively transfer electromagnetic power with high efficiency. Leviticus Cardio served the Health Tech & Life Sciences sector, specifically focusing on Medical Devices and Medical Treatment & Therapeutics for healthcare providers globally.
Strategic signal
In March 2026, Leviticus Cardio ceased operations, indicating a significant shift in its corporate trajectory. This development signals to investors and innovation teams that the company's pioneering work in wireless VAD power solutions has concluded, potentially opening opportunities for other players in the medical device and cardiovascular treatment sectors to address the market need for improved VAD technology.
Log in to access full profile ›Company Intelligence Q&A
- What is Leviticus Cardio's primary focus?
- Leviticus Cardio developed a wireless system to power implanted ventricular assist devices (VADs), aiming to eliminate complications related to traditional drive lines.
- What is the status of Leviticus Cardio?
- Leviticus Cardio is currently non-active and ceased to operate in March 2026.
- When was Leviticus Cardio founded and by whom?
- Leviticus Cardio was founded in February 2008 by Michael Zilbershlag, Yigal Kassif, and Moshe Levy.
- Did Leviticus Cardio receive any grants?
- Yes, in January 2019, Leviticus Cardio and Jarvik Heart were awarded an R&D grant from the BIRD Foundation. Additionally, in December 2016, the company received a grant from the Office of the Chief Scientist.
- What was a key technological achievement for Leviticus Cardio?
- In February 2019, the company's wireless heart pump technology was implanted in a patient for the first time, marking a significant milestone in its development.